Natalizumab in clinical practice: managing the risks, enjoying the benefits

被引:3
|
作者
Aktas, Orhan [1 ]
机构
[1] Univ Dusseldorf, Dept Neurol, Fac Med, D-40225 Dusseldorf, Germany
来源
关键词
MULTIPLE-SCLEROSIS; EFFICACY;
D O I
10.1136/jnnp-2013-307355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1181 / 1181
页数:1
相关论文
共 50 条
  • [1] Managing the risks and benefits of clinical research in response to a pandemic
    Flume, Patrick A.
    Berbari, Elie F.
    Viera, Laura
    Hess, Rachel
    Higgins, Janine
    Armstrong, Jennifer
    Rice, Linda
    True, Laura
    Shaker, Reza
    Buse, John B.
    Panettieri, Reynold A., Jr.
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 5 (01)
  • [2] Which fish to eat: enjoying the benefits while minimizing the risks
    Toppe, Jogeir
    [J]. INTERNATIONAL CONFERENCE OF SABARAGAMUWA UNIVERSITY OF SRI LANKA 2015 (ICSUSL 2015), 2016, 6 : 47 - 50
  • [3] Defining benefits and risks for SERMs in clinical trials and clinical practice
    Johnson, SR
    Dunn, BK
    Anthony, M
    [J]. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 304 - 314
  • [4] Weighing the benefits and risks of oral immunotherapy in clinical practice
    Anagnostou, Aikaterini
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (02) : 118 - 123
  • [5] VIGOROUS EXERCISE IN CLINICAL PRACTICE: BALANCING RISKS AND BENEFITS
    Felix Mediano, Mauro Felippe
    Mattos Pinto, Vivian Liane
    Nogueira, Fernanda de Souza
    Mendes, Sardinha
    Sperandio Silva, Gilberto Marcelo
    Sousa, Andrea Silvestre
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (05): : 1053 - 1053
  • [6] Benefits, pitfalls and risks of phytotherapy in clinical practice in otorhinolaryngology
    Laccourreye, O.
    Werner, A.
    Laccourreye, L.
    Bonfils, P.
    [J]. EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2017, 134 (02) : 95 - 99
  • [7] Weighing the benefits and risks in clinical trials and practice - Introduction
    McCaskill-Stevens, W
    [J]. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 279 - 279
  • [8] The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
    Singer, Barry A.
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (09) : 327 - 336
  • [9] Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
    Dorsey, E. R.
    Thompson, J. P.
    Noyes, K.
    Dick, A. W.
    Holloway, R. G.
    Schwid, S. R.
    [J]. NEUROLOGY, 2007, 68 (18) : 1524 - 1528
  • [10] Enjoying the Benefits
    Gennaro, Susan
    [J]. JOURNAL OF NURSING SCHOLARSHIP, 2016, 48 (06) : 531 - 532